<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        15-290-01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NEOPRED - P
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        POLYMYXIN B,PREDNISOLONE,NEOMYCIN SULFATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10000,5,5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        6.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Amman Pharmaceutical Industries (API)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Amman Pharmaceutical Industries (API)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Amman Pharmaceutical Industries (API)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01CA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>A steroid/anti-infective combination is indicated for steroid-responsive inflammatory ocular conditions<br />for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection<br />exists.<br />Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva,<br />cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective<br />conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated<br />in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetration<br />of foreign bodies.<br />The use of a combination drug with an anti-infective component is indicated where the risk of infection<br />is high or where there is an expectation that potentially dangerous numbers of bacteria will be present<br />in the eye.<br />The particular anti-infective drugs in this product are active against the following common bacterial eye<br />pathogens: Staphylococcus aureus; Escherichia coli; Hemophilus influenzae; Klebsiella/ Enterobacter<br />species; Neisseria species; and Pseudomonas aeruginosa.<br />The product does not provide adequate coverage against: Serratia marcescens; Streptococci,<br />including Streptococcus pneumoniae.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Neopred-P in these cases:<br />1. Epithelial herpes simplex keratitis (dendritic keratitis)<br />2. vaccinia, varicella, and many other viral diseases of the cornea and conjunctiva.<br />3. Mycobacterial infection of the eye.<br />4. Fungal diseases of the ocular structures.<br />5. Hypersensitivity to a component of the medication. (Hypersensitivity to the antibiotic component occurs at<br />a higher rate than for other components)<br />6. The use of these combinations is always contraindicated after uncomplicated removal of a corneal foreign<br />body.</p><p>Take special care with Neopred-P .Tell your doctor if:<br />The initial prescription and renewal of the medication order beyond 20 milliliters should be made by a<br />physician only after examination of the patient with the aid of magnification, such as slit lamp<br />biomicroscopy and, where appropriate, fluorescein staining.<br />The possibility of persistent fungal infections of the cornea should be considered after prolonged<br />steroid dosing.<br />As with other antimicrobial preparations, prolonged use may result in overgrowth of nonsusceptible<br />organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated.<br />Bacterial resistance to Neopred-P suspension may also develop. If purulent discharge, inflammation,<br />or pain becomes aggravated, the patient should discontinue use of the medicatioin and consult a<br />physician<br />Allergic cross-reactions may occur which could prevent the use of any or all of the following antibiotics<br />for the treatment of future infections: kanamycin, paromomycin, streptomycin, and possibly<br />gentamicin.<br />Warnings<br />Not for injection into the eye<br />Prolonged use may result in glaucoma, with damage to the optic nerve, defects in visual acuity and fields of<br />vision, and in posterior subcapsular cataract formation. Prolonged use may suppress the host response and<br />thus increase the hazard of secondary ocular infections. In those diseases causing thinning of the cornea or<br />sclera, perforations have been known to occur with the use of topical steroids. In acute purulent conditions of<br />the eye, steroids may mask infection or enhance existing infection. If these products are used for 10 days or<br />longer, intraocular pressure should be routinely monitored even though it may be difficult in children and<br />uncooperative patients.</p><p>Employment of a steroid medication in the treatment of herpes simplex requires great caution.<br />There exists a potential for neomycin sulfate to cause cutaneous sensitization. The exact incidence of this<br />reaction is unknown. The manifestations of sensitization to topical antibiotics are usually itching, reddening,<br />and edema of the conjunctiva and eyelid. A sensitization reaction may manifest simply as a failure to heal.<br />During long-term use of topical antibiotic products, periodic examination for such signs is advisable, and the<br />patient should be told to discontinue the product if they are observed. Symptoms usually subside quickly on<br />withdrawing the medication. Application of products containing these ingredients should be avoided for the<br />patient thereafter.<br />Taking other medicines:<br />There are no known important interactions between Neopred-P and other medicines. If you<br />experience any unusual symptoms while using it with other medicines you should tell your doctor.<br />Pregnancy and breast-feeding:<br />Neomycin/polymyxin B/prednisolone ophthalmic has been assigned to pregnancy category C by the<br />FDA. Animal studies have shown corticosteroids to be teratogenic in mice and rabbits following<br />multiple dose topical ophthalmic application. There are no controlled data in human pregnancy.<br />Neopred-P is only recommended for use during pregnancy when there are no alternatives and benefit<br />outweighs risk.<br />Corticosteroids have been shown to produce fetal resorptions and cleft palate in mice. In addition, they<br />have produced fetal resorptions and multiple abnormalities involving the head, ears, limbs, and palate<br />in rabbits.<br />Topically applied steroids have been reported to be absorbed systemically. The manufacturer<br />recommends that due to the potential for serious adverse reactions in nursing infants, a decision<br />should be made to discontinue the drug or to discontinue nursing, taking into account the importance<br />of the drug to the mother. Prednisolone is considered compatible with breast-feeding by the American<br />Academy of Pediatrics.<br />This drug is excreted in human milk. Caution should be exercised when Neopred-P is administered to<br />a nursing woman.<br />Driving and using machines:<br />Your eyesight may become blurred for a short time following the use of Neopred-P. You must not drive<br />or operate hazardous machines until your eyesight has returned to normal.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>To treat the eye: Instill 1 or 2 drops every 3 or 4 hours, or more frequently as required. Acute infections<br />may require administration every 30 minutes, with frequency of administration reduced as the infection<br />is brought under control.<br />To treat the lids: Instill 1 or 2 drops in the eye every 3 to 4 hours, close the eye and rub the excess on<br />the lids and lid margins.<br />Not more than 20 milliliters should be prescribed initially and the prescription should not be refilled<br />without further evaluation.<br />To treat the ear: instill 1 or 2 drops of Neopred-P into the affected ear 3 or 4 times daily.<br />If anyone has too much<br />Overdosage will not ordinarily cause acute problems. If accidental overdosage occurs in the eye, flush<br />the eye with water or normal saline. If accidentally ingested, drink fluids to dilute and contact your<br />doctor or your nearest hospital casualty unit.<br />If you forget to use Neopred-P Eye Drops:<br />Do not use a double dose to make up for the forgotten dose. Use the next dose at usual time.<br />If you stop using Neopred-P Eye Drops:<br />Please speak to your doctor or pharmacist before stopping any medicine. If you have any further<br />questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Hypersensitivity<br />Hypersensitivity reactions have occurred due to allergic sensitization.<br />Ocular<br />Ocular side effects associated with the corticosteroid component have included elevated intraocular<br />pressure with possible development of glaucoma, optic nerve damage, posterior subcapsular cataract<br />formation, and delayed wound healing. In addition, perforation of the cornea and sclera have occurred<br />when administering topical steroids to patients with diseases that cause thinning of the cornea or<br />sclera.</p><p>Other<br />The development of a secondary infection has been reported in patients treated with<br />antimicrobial and corticosteroid combinations. Fungal and viral infections of the cornea can<br />develop with long-term application of corticosteroids.<br />Adverse Reactions<br />Adverse reactions have occurred with steroid/anti-infective combination drugs which can be<br />attributed to the steroid component, the anti-infective component, or the combination. Exact<br />incidence figures are not available since no denominator of treated patients is available.<br />Reactions occurring most often from the presence of the anti-infective ingredients are allergic<br />sensitizations including itching, swelling, and conjunctival erythema.<br />Serious hypersensitivity reactions, including anaphylaxis, have been reported rarely.The<br />reactions due to the steroid component in decreasing order of frequency are: elevation of<br />intraocular pressure (IOP) with possible development of glaucoma, and infrequent optic nerve<br />damage; posterior subcapsular cataract formation; and delayed wound healing.<br />Although systemic effects are extremely uncommon, there have been rare occurrences of<br />systemic hypercorticoidism after use of topical steroids.<br />Corticosteroid-containing preparations have also been reported to cause perforation of the globe.<br />Keratitis, conjunctivitis, corneal ulcers, and conjunctival hyperemia have occasionally been<br />reported following local use of steroids.<br />Secondary infection: The development of secondary infection has occurred after use of<br />combinations containing steroids and antimicrobials. Fungal infections of the cornea are<br />particularly prone to develop coincidentally with long-term applications of steroids. The possibility<br />of fungal invasion must be considered in any persistent corneal ulceration where steroid<br />treatment has been used.<br />Secondary bacterial ocular infection following suppression of host responses also occurs.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Store between 15-25oC.<br />- Discard bottle four weeks after opening.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient: Prednisolone acetate 5 mg/ml, Neomycin sulphate 5 mg/ml, Polymixin-B<br />sulphate 10000 I.U.<br />Other ingredients are: Sodium acetate, Sodium chloride, Propylene glycol, Tween 80,<br />Hydroxypropylmethylcellulose, Thiomersal 0.01 mg/ml as preservative and highly purified water.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Presentation: 10 ml plastic dropper bottle.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing authorization holder and Manufacturer:<br />Amman Pharmaceutical Industries<br />King Abdullah II Ind Estat-Sahab-Amman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يستخدم مزیج الستيرويد&nbsp;ومضاد الالتهاب&nbsp;للحالات العينية الالتهابية التي تستجيب للستيرويد والتي یشار إلیھا<br />بالستيرويدات&nbsp;القشرية&nbsp;وحيث&nbsp;یوجد التھاب بكتيري أو خطر الإصابة بالتھاب بكتيري في العين.<br />يشار إلى الستيرويدات العينية&nbsp;في حالات التھاب الملتحمة الجفنية&nbsp;والنخامية&nbsp;، والقرنية&nbsp;، والجزء الأمامي من<br />كرة العين&nbsp;حيث&nbsp;يكون&nbsp;الخطر الكامن لاستخدام الستيرويد&nbsp;في حالات محددة من التھاب الملتحمة مقبولاً للتخفيف<br />من الوذمة والالتھاب. وتستخدم أیضاً في حالات التھاب القزحیة الأمامي المزمن وإصابة القرنیة من الحروق<br />الكیمیائیة أو الإشعاعیة أو الحراریة أو دخول الأجسام الغریبة.<br />استخدام الدواء المركب مع مكون مضاد للالتھاب یشار إلیھ عندما یكون خطر الإصابة مرتفعًا أو عندما یكون ھناك<br />توقع بوجود أعداد خطیرة من البكتیریا في العین<br />الأدویة المضادة للالتھاب المخصصة في ھذا المستحضر تنشط ضد مسببات الأمراض البكتیریة الشائعة : المكورات<br />العنقودیة الذھبیة و الإشریكیة القولونیة و المستدمیة النزلیة و أنواع كلیبسیلا إنتیروباكتر وأنواع النیسیریة وكذلك<br />الزائفة الزنجاریة.<br />لا یوفر المنتج تغطیة كافیة ضد سیراتیا مارسیسنس والمكورات العقدیة بما في ذلك المكورات العقدیة الرئویة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تستخدم نیوبرد-ب في الحالات التالیة:<br />۱. التھاب القرنیة الھربس الظھاري البسیط (التھاب القرنیة شجیري)<br />۲. اللقاح ، الحماق (جدري الماء)، والعدید من الأمراض الفیروسیة للقرنیة والملتحمة.<br />۳. العدوى الفطریة البكتیریة للعین.<br />٤. الأمراض الفطریة في أجزاء العین.<br />٥. فرط الحساسیة لمكون من الدواء. (فرط الحساسیة للمضاد الحیوي یحدث بمعدل أعلى من المكونات الأخرى)<br />٦. استخدام ھذا المزیج دائما یمنع بعد إزالة بسیطة لجسم غریب من القرنیة.<br />كن حذراً عند استعمال نیوبرد &ndash; ب أخبر طبیبك إذا:<br />یجب أن لا یقوم الطبیب بوصف الدواء لأول مرة وتجدید صرفھ لأكثر من ۲۰ ملیلتر إلا بعد فحص المریض<br />بمساعدة التكبیر ، مثل التنظیر الحیوي للمصباح الشقي ، وإذا لزم الأمر تلطیخ فلوریسئین.<br />ینبغي الأخذ بعین الاعتبار احتمالیة حدوث الالتھابات الفطریة المستمرة للقرنیة بعد الاستعمال المطول للستیروید.<br />كما ھو الحال مع المستحضرات الأخرى المضادة للمیكروبات ، قد یؤدي الاستخدام المطول إلى نمو مفرط للكائنات<br />غیر الحساسة ، بما في ذلك الفطریات. في حالة حدوث عدوى ، یجب البدء في العلاج المناسب.<br />قد تتطور أیضًا المقاومة البكتیریة لمعلق نیوبرد-ب. في حالة تفاقم إفرازات قیحیة أو التھاب أو ألم ، یجب على<br />المریض التوقف عن استخدام الدواء واستشارة الطبیب.<br />قد تحدث تفاعلات تحسسیة قد تمنع استخدام أي من المضادات الحیویة التالیة أو كلھا لعلاج الالتھابات القادمة:<br />الكانامایسین ، البارومومایسین ، الستربتومایسین ، وربما الجنتامیسین.<br />المحاذیر<br />لا یستخدم للحقن في العین<br />الاستخدام المطول قد یؤدي إلى الجلوكوما ، مع حدوث تلف في العصب البصري ، وتشوھات في حدة البصر<br />وحقول الرؤیة وفي تكوین الساد تحت المحفظة الخلفي. الاستخدام المطول قد یثبط استجابة العائل وبالتالي یزید من<br />خطر الالتھابات العینیة الثانویة. في تلك الأمراض التي تسبب ترقق القرنیة أو الصلبة العینیة ، من المعروف أن<br />الثقوب تحدث عند استخدام الستیرویدات الموضعیة. في ظروف صدیدي العین الحادة ، قد تحجب الستیرویدات<br />الالتھاب أو تعزز الالتھاب الموجود. إذا تم استخدام ھذه المنتجات لمدة ۱۰ أیام أو أكثر ، فیجب مراقبة الضغط<br />داخل العین بشكل روتیني على الرغم من أنھ قد یكون من الصعب على الأطفال والمرضى غیر المتعاونین.<br />توظیف دواء الستیروید في علاج الھربس البسیط یتطلب الحذر الشدید.</p><p>یوجد احتمال أن تسبب سلفات النیومیسین حساسیة جلدیة. الإصابة الدقیقة لھذا التفاعل غیر معروفة. عادة ما تكون<br />مظاھر الحساسیة للمضادات الحیویة الموضعیة ھي الحكة ، الاحمرار ، وذمة الملتحمة والجفن.<br />رد الفعل التحسسي قد یظھر ببساطة على أنھ فشل في الشفاء. أثناء الاستخدام طویل المدى لمنتجات المضادات<br />الحیویة الموضعیة ، یُنصح بإجراء فحص دوري لمثل ھذه العلامات ، ویجب إخبار المریض بالتوقف عن المنتج<br />إذا تمت ملاحظتھ. عادة ما تھدأ الأعراض بسرعة عند سحب الدواء. یجب تجنب تطبیق المنتجات التي تحتوي<br />على ھذه المكونات للمریض بعد ذلك.<br />استخدام أدویة أخرى:<br />لا توجد تفاعلات مھمة معروفة بین نیوبرد-ب والأدویة الأخرى. إذا واجھت أي أعراض غیر اعتیادیة أثناء<br />استخدامھ مع أدویة أخرى ، یجب علیك إخبار طبیبك.<br />الحمل والرضاعة الطبیعیة<br />من قبل إدارة الأغذیة والعقاقیر. C تم تصنیف نیومایسین / بولیمیكسین ب / بریدنیزولون للعینین إلى فئة الحمل<br />أظھرت الدراسات التي أجریت على الحیوانات أن الكورتیكوستیرویدات لھا تأثیرات مسخیة في الفئران والأرانب<br />بعد تطبیق القطرة عدة مرات في العیون. لا توجد بیانات خاضعة للرقابة في الحمل عند البشر.<br />ینصح باستخدام نیوبرد-ب أثناء الحمل فقط إذا لم یكون ھناك بدائل أو كانت الاستفادة تفوق المخاطر.<br />وقد أظھرت الكورتیكوستیرویدات إنتاج ارتشافات الجنین والحنك المشقوق في الفئران. بالإضافة إلى ذلك ،قد<br />أنتجت الكورتیكوستیرویدات ارتشافات جنینیة وتشوھات متعددة تشمل الرأس والأذنین والأطراف والحنك عند<br />الأرانب.<br />تم الإبلاغ عن امتصاص الستیرویدات الموضعیة جھازیاً. توصي الشركة المصنعة أنھ بسبب احتمال حدوث ردود<br />فعل سلبیة خطیرة عند الرضع طبیعیاً ، یجب اتخاذ قرار لوقف الدواء أو وقف الرضاعة ، مع مراعاة أھمیة الدواء<br />للأم. یعتبر بریدنیزولون متوافقاً مع الرضاعة الطبیعیة حسب الأكادیمیة الأمریكیة لطب الأطفال.<br />یفرز ھذا الدواء في حلیب الأم. یجب توخي الحذر عند إعطاء نیوبرد-ب للمرأة المرضعة.<br />القیادة واستخدام الآلات<br />قد تصبح الرؤیة لدیك غیر واضحة لفترة قصیرة بعد استخدام نیوبرد-ب. یجب علیك عدم قیادة السیارة أو تشغیل<br />آلات خطرة حتى یعود بصرك إلى وضعھ الطبیعي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لعلاج العین: ضع قطرة واحدة أو قطرتین كل ۳ أو ٤ ساعات ، أو كرر ذلك كما ھو مطلوب. قد تتطلب الالتھابات<br />الحادة تطبیق الدواء كل ۳۰ دقیقة ، مع تقلیل تكرار الاستخدام إذا كان الالتھاب تحت السیطرة.<br />لعلاج الجفون: ضع قطرة واحدة أو قطرتین كل ۳ أو ٤ ساعات ، أغلق العین وافرك الزائد على الجفون والمنطقة<br />المحیطة بالجفون .<br />لا ینبغي أن یوصف ما لا یزید عن ۲۰ مللیلتر في البدایة ولا ینبغي إعادة وصف الدواء دون عمل تقییم مفصل للحالة.<br />إذا تم استخدام جرعة زائدة<br />الجرعة الزائدة لا تسبب عادة مشاكل حادة. إذا حدث بالخطأ زیادة في الجرعة في العین ، غطس العین بالماء أو<br />بالمحلول الملحي الطبیعي. إذا قمت بابتلاع القطرات عن طریق الخطأ تناول السوائل حتى تقوم بتخفیفھ أواتصل<br />بطبیبك أو أقرب وحدة إصابات بالمستشفى.<br />إذا نسیت استخدام قطرة العین نیوبرد-ب<br />لا تستخدم جرعة مضاعفة لتعویض الجرعة المنسیة ، استخدم الجرعة التالیة كالمعتاد.<br />إذا توقفت عن استخدام قطرة العین نیوبرد-ب<br />تحدث إلى طبیبك أو الصیدلاني قبل أن تتوقف عن استخدام أي دواء. إذا كان لدیك أي أسئلة إضافیة حول استخدام<br />ھذا المستحضر ,اسأل طبیبك أو الصیدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>فرط الحساسیة<br />حدثت تفاعلات فرط الحساسیة بسبب الحساسیة.<br />بصریة<br />تضمنت الآثار الجانبیة للعین المرتبطة بالكورتیكوستیروید ارتفاع الضغط داخل العین مع احتمال تطور الجلوكوما<br />وتلف الأعصاب البصریة وتشكیل الساد تحت المحفظة الخلفي وتأخر التئام الجروح. بالإضافة إلى ذلك ، حدوث<br />ثقوب في القرنیة والصلبة عند استخدام الستیرویدات الموضعیة للمرضى الذین یعانون من الأمراض التي تسبب<br />ترقق القرنیة أو الصلبة.<br />أعراض أخرى<br />تم الإبلاغ عن تطور التھاب ثانوي عند المرضى الذین عولجوا بتركیبة مضادات المیكروبات والكورتیكوستیروید.<br />یمكن أن تتطور الالتھابات الفطریة والفیروسیة للقرنیة في حال الاستعمال المطول للستیرویدات القشریة.</p><p>ردود الفعل العكسیة<br />حدثت ردود فعل عكسیة عند استخدام تركیبة الستیروید ومضاد الالتھاب والتي یمكن أن تعزى إلى مكون الستیروید ،<br />مكون مضاد الالتھاب ، أو المزیج. الرقم الدقیق لحدوث ردود الفعل لا یمكن ذكره حیث أنھ لا یوجد حالات مرضیة.<br />ردود الفعل التي تحدث في معظم الأحیان من وجود المكونات المضادة للالتھاب ھي الانفعال التحسسي بما في ذلك<br />الحكة ، تورم ، حمامي الملتحمة .<br />تفاعلات فرط الحساسیة الخطیرة ، بما في ذلك الحساسیة المفرطة ھي نادرة الحدوث.<br />ردود الفعل التي تحدث بسبب مكون الستیروید في عدد مرات متناقص ھي : ارتفاع الضغط داخل العین مع احتمال<br />تطور الجلوكوما وتلف الأعصاب البصریة النادرة وتشكل الساد تحت المحفظة الخلفي. وتأخر التئام الجروح<br />على الرغم من أن التأثیرات الجھازیة غیر شائعة للغایة ، فقد كانت ھناك حالات نادرة من فرط كورتیكویدیة الجھازیة<br />بعد استخدام الستیرویدات الموضعیة.<br />كما تم الإبلاغ أن المركبات التي تحتوي على كورتیكوستیروید لتسبب ثقب في كرة العین, التھاب القرنیة ، التھاب<br />الملتحمة ، قرحة القرنیة ، احتقان الملتحمة تم الإبلاغ عنھا أحیانًا بعد استخدام الستیرویدات.<br />الالتھابات الثانویة: حدث تطور الالتھابات الثانویة بعد استخدام تركیبات تحتوي على الستیرویدات ومضادات<br />المیكروبات. الالتھابات الفطریة للقرنیة عرضة بشكل خاص للظھور عن طریق الصدفة مع الاستخدام طویل الأمد<br />للستیرویدات. یجب النظر في احتمال الغزو الفطري في حال حدوث أي حالة تقرح في القرنیة المستمر عند استخدام<br />العلاج بالستیرویدات.<br />التھابات العین البكتیریة الثانویة التي تلي تثبیط استجابة العائل قد تحدث أیضاً.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- يحفظ بدرجة حرارة بين 15-25 درجة مئوية<br />- تخلص من العبوة بعد مضي أربعة أسابیع على فتحھا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المواد الفعالة:خلات البریدنیزولون ٥ ملغم / مل، كبریتات النیومایسین ٥ ملغم / مل، كبریتات البولیمیكسین-ب<br />۱۰٫۰۰۰ و.د<br />المكونات الأخرى:خلات الصودیوم، كلورید الصودیوم، بروبیلین غلیكول، توین ۸۰ ، ھایدروكسي بروبل میثل سیلیلوز،<br />ثیومیرسال ۰٫۰۱ ملغم/مل كمادة حافظة ومیاه عالیة النقاوة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>التعبئة: یتوفر في عبوات بلاستیكیة مزودة بقطارة سعة ۱۰ مل.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة عمان للصناعات الدوائیة<br />مدينة الملك عبدالله الثاني الصناعية-سحاب-عمان</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            1/2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Neopred-P Eye/ Ear Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prednisolone acetate 0.5% Neomycin sulphate 0.5% Polymyxin B sulphate 1,000,000 IU For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye Drops
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A steroid/anti-infective combination is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.<br />Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetration of foreign bodies.<br />The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.<br />The particular anti-infective drugs in this product are active against the following common bacterial eye pathogens: Staphylococcus aureus; Escherichia coli; Hemophilus influenzae; Klebsiella/ Enterobacter species; Neisseria species; and Pseudomonas aeruginosa.<br />The product does not provide adequate coverage against: Serratia marcescens; Streptococci, including Streptococcus pneumoniae.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TO TREAT THE EYE: Instill 1 or 2 drops every 3 or 4 hours, or more frequently as required. Acute infections may require administration every 30 minutes, with frequency of administration reduced as the infection is brought under control. TO TREAT THE LIDS: Instill 1 or 2 drops in the eye every 3 to 4 hours, close the eye and rub the excess on the lids and lid margins.<br />Not more than 20 milliliters should be prescribed initially and the prescription should not be refilled without further evaluation as outlined in the PRECAUTIONS section above.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and many other viral diseases of the cornea and conjunctiva. Mycobacterial infection of the eye. Fungal diseases of the ocular structures.
Hypersensitivity to a component of the medication. (Hypersensitivity to the antibiotic component occurs at a higher rate than for other components.)
The use of these combinations is always contraindicated after uncomplicated removal of a corneal foreign body.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NOT FOR INJECTION INTO THE EYE.<br />Prolonged use may result in glaucoma, with damage to the optic nerve, defects in visual acuity and fields of vision, and in posterior subcapsular cataract formation. Prolonged use may suppress the host response and thus increase the hazard of secondary ocular infections. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. In acute purulent conditions of the eye, steroids may mask infection or enhance existing infection. If these products are used for 10 days or longer, intraocular pressure should be routinely monitored even though it may be difficult in children and uncooperative patients.<br />Employment of a steroid medication in the treatment of herpes simplex requires great caution.<br />There exists a potential for neomycin sulfate to cause cutaneous sensitization. The exact incidence of this reaction is unknown. The manifestations of sensitization to topical antibiotics are usually itching, reddening, and edema of the conjunctiva and eyelid. A sensitization reaction may manifest simply as a failure to heal. During long-term use of topical antibiotic products, periodic examination for such signs is advisable, and the patient should be told to discontinue the product if they are observed. Symptoms usually subside quickly on withdrawing the medication. Application of products containing these ingredients should be avoided for the patient thereafter.</p><p>Precautions<br />General:<br />The initial prescription and renewal of the medication order beyond 20 milliliters should be made by a physician only after examination of the patient with the aid of magnification, such as slit lamp biomicroscopy and, where appropriate, fluorescein staining.</p><p>The possibility of persistent fungal infections of the cornea should be considered after prolonged steroid dosing.<br />As with other antimicrobial preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated.<br />Bacterial resistance to Neopred-P may also develop. If purulent discharge, inflammation, or pain becomes aggravated, the patient should discontinue use of the medicatioin and consult a physician.<br />Allergic cross-reactions may occur which could prevent the use of any or all of the following antibiotics for the treatment of future infections: kanamycin, paromomycin, streptomycin, and possibly gentamicin.<br />Children Safety and effectiveness in pediatric patients have not been established. Secondary infection<br />The development of secondary infection has occurred after use of combinations containing steroids and antimicrobials. Fungal infections of the cornea are particularly prone to develop coincidentally with long-term applications of steroids. The possibility of fungal invasion must be considered in any persistent corneal ulceration where steroid treatment has been used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None well documented.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Neomycin/polymyxin B/prednisolone ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have shown corticosteroids to be teratogenic in mice and rabbits following multiple dose topical ophthalmic application. There are no controlled data in human pregnancy.<br />Neomycin/polymyxin B/prednisolone ophthalmic is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.<br />Corticosteroids have been shown to produce fetal resorptions and cleft palate in mice. In addition, they have produced fetal resorptions and multiple abnormalities involving the head, ears, limbs, and palate in rabbits.</p><p>Lactation<br />Topically applied steroids have been reported to be absorbed systemically. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the&nbsp;importance of the drug to the mother. Prednisolone is considered compatible with breast-feeding by the American Academy of Pediatrics.<br />This drug is excreted in human milk. Caution should be exercised when (prednisolone, neomycin and polymyxin b) ophthalmic suspension is administered to a nursing woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Temporary blurred vision and stinging of the eye are the most common side effects and to contact health care provider if these symptoms occur and are bothersome. Patients must be advised not to drive or operate machines until clear vision is restored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypersensitivity<br />Hypersensitivity reactions have occurred due to allergic sensitization.<br />Ocular<br />Ocular side effects associated with the corticosteroid component have included elevated intraocular pressure with possible development of glaucoma, optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing. In addition, perforation of the cornea and sclera have occurred when administering topical steroids to patients with diseases that cause thinning of the cornea or sclera.<br />Other<br />The development of a secondary infection has been reported in patients treated with antimicrobial and corticosteroid combinations. Fungal and viral infections of the cornea can develop with long-term application of corticosteroids.<br />Adverse Reactions<br />Adverse reactions have occurred with steroid/anti-infective combination drugs which can be attributed to the steroid component, the anti-infective component, or the combination. Exact incidence figures are not available since no denominator of treated patients is available.<br />Reactions occurring most often from the presence of the anti-infective ingredients are allergic sensitizations including itching, swelling, and conjunctival erythema. More serious hypersensitivity reactions, including anaphylaxis, have been reported rarely. The reactions due to the steroid component in decreasing order of frequency are: elevation of intraocular pressure (IOP) with possible development of glaucoma, and infrequent optic nerve damage; posterior subcapsular cataract formation; and delayed wound healing.<br />Although systemic effects are extremely uncommon, there have been rare occurences of systemic hypercorticoidism after use of topical steroids.<br />Corticosteroid-containing preparations have also been reported to cause perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, and conjunctival hyperemia have occasionally been reported following local use of steroids.</p><p>Secondary infection: The development of secondary infection has occurred after use of combinations containing steroids and antimicrobials. Fungal infections of the cornea are particularly prone to develop coincidentally with long-term applications of steroids. The possibility of fungal invasion must be considered in any persistent corneal ulceration where steroid treatment has been used.<br />Secondary bacterial ocular infection following suppression of host responses also occurs.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No information provided.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Corticosteroids suppress the inflammatory response to a variety of agents and they probably delay or slow healing. Since corticosteroids may inhibit the body&#39;s defense mechanism against infection, a concomitant antimicrobial drug may be used when this inhibition is considered to be clinically significant in a particular case.<br />The anti-infective components in Neopred-P are included to provide action against specific organisms susceptible to them. Neomycin sulfate and polymyxin B sulfate are considered active against the following microorganisms: Staphylococcus aureus; Escherichia coli; Hemophilus influenzae; Klebsiella/ Enterobacter species; Neisseria species; and Pseudomonas aeruginosa.<br />When a decision to administer both a corticosteroid and an antimicrobial is made, the administration of such drugs in combination has the advantage of greater patient compliance and convenience, with the added assurance that the appropriate dosage of both drugs is administered. When both types of drugs are in the same formulation, compatibility of ingredients is assured and the correct volume of drug is delivered and retained.<br />The relative potency of corticosteroids depends on the molecular structure, concentration and release from the vehicle.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not available</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium acetate Sodium chloride Propylene glycol Tween 80 Hydroxypropyl methylcellulose (Hypermellose 2911) Thiomersal Highly purified water.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No information provided.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C. Discard contents four weeks after opening.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>LDPE bottle with LDPE dropper and HDPE cap.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amman Pharmaceutical Industries (API). Jordan / Amman, Sahab, Second King Abdullah II Industrial City. Tel: +962-6-4023072 Fax: +962-6-4023071 E-mail: info@ammanpharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                20/06/2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>